Pregled bibliografske jedinice broj: 1234207
Impact of pharmacotherapeutic education on medication adherence and adverse outcomes in patients with type 2 diabetes mellitus: a prospective, randomized study
Impact of pharmacotherapeutic education on medication adherence and adverse outcomes in patients with type 2 diabetes mellitus: a prospective, randomized study // Croatian medical journal, 59 (2018), 6; 290-297 doi:10.3325/cmj.2018.59.290 (recenziran, članak, znanstveni)
CROSBI ID: 1234207 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Impact of pharmacotherapeutic education on
medication adherence and adverse outcomes in
patients with type 2 diabetes mellitus: a
prospective, randomized study
Autori
Marušić, Srećko ; Meliš, Petra ; Lucijanić, Marko ; Grgurević, Ivica ; Turčić, Petra ; Obreli Neto, Paulo Roque ; Bilić-Ćurčić, Ines
Izvornik
Croatian medical journal (0353-9504) 59
(2018), 6;
290-297
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
diabetes ; education
Sažetak
Aim: To evaluate the impact of pharmacotherapeutic education on 30-day post-discharge medication adherence and adverse outcomes in patients with type 2 diabetes mellitus (T2DM). Methods: The prospective, randomized, single- center study was conducted at the Medical Department of University Hospital Dubrava, Zagreb, between April and June 2018. One hundred and thirty adult patients with T2DM who were discharged to the community were randomly assigned to either the intervention or the control group. Both groups during the hospital stay received the usual diabetes education. The intervention group received additional individual pre-discharge pharmacotherapeutic education about the discharge prescriptions. Medication adherence and occurrence of adverse outcomes (adverse drug reactions, readmission, emergency department visits, and death) were assessed at the follow-up visit, 30 days after discharge. Results: The number of adherent patients was significantly higher in the intervention group (57/64 [89.9%] vs 41/61 [67.2%] ; χ2 test, P=0.003]. There was no significant difference between the groups in the number of patients who experienced adverse outcomes (31/64 [48.4%] vs 36/61 [59.0%] ; χ2 test, P=0.236). However, higher frequencies of all adverse outcomes were consistently observed in the control group. Conclusion: Pharmacotherapeutic education of patients with T2DM can significantly improve 30- day post-discharge medication adherence, without a significant reduction in adverse clinical outcomes.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Javno zdravstvo i zdravstvena zaštita, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Medicinski fakultet, Zagreb,
Klinička bolnica "Dubrava",
Medicinski fakultet, Osijek
Profili:
Petra Turčić
(autor)
Srećko Marušić
(autor)
Marko Lucijanic
(autor)
Ivica Grgurević
(autor)
Petra Meliš
(autor)
Ines Bilić-Ćurčić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE